Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Emergent BioSolutions Community
NYSE:EBS Community
1
Narratives
written by author
1
Comments
on narratives written by author
23
Fair Values set
on narratives written by author
Community Investing Ideas
Emergent BioSolutions
Popular
Undervalued
Overvalued
Emergent BioSolutions
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Global MCM Demand And Political Risks Will Shape Outlook
Key Takeaways Growing government demand and global expansion drive revenue predictability, diversification, and increased stability across medical countermeasure and health preparedness markets. Improved operating efficiency and financial strength enable greater investment in innovation, supporting sustained growth and enhanced earnings potential.
View narrative
US$13.50
FV
34.5% undervalued
intrinsic discount
-4.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
EBS
EBS
Emergent BioSolutions
Your Fair Value
US$
Current Price
US$8.84
79.7% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-602m
2b
2015
2018
2021
2024
2025
2027
2030
Revenue US$672.3m
Earnings US$110.1m
Advanced
Set Fair Value